{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T11:50:52Z","timestamp":1775994652283,"version":"3.50.1"},"posted":{"date-parts":[[2025,6,19]]},"group-title":"Cancer Biology","reference-count":38,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"United States Department of Defense","doi-asserted-by":"crossref","award":["W81XWH-22-1-1002"],"award-info":[{"award-number":["W81XWH-22-1-1002"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"United States Department of Defense","doi-asserted-by":"crossref","award":["BC211016"],"award-info":[{"award-number":["BC211016"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"crossref","award":["AU-0042-20030616"],"award-info":[{"award-number":["AU-0042-20030616"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"crossref","award":["RP190561"],"award-info":[{"award-number":["RP190561"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  We have previously reported a cyclic peptide CRAGVGRGC (termed BLMP6) that homes to disseminating tumor cells in mouse cancer models and could be used for metastasis detection and intervention. Here, based on BLMP6 similarity to latent transforming growth factor beta binding protein 4 (LTBP4), we discovered fibulin-4 as a BLMP6 target. We show that BLMP6 mimics the LTBP4 domain binding to fibulin-4 and selectively binds to fibulin-4 in vitro. Fibulin-4 knockout in mouse 4T1 cancer cells abrogated BLMP6 homing to lung metastases. Fibulin-4 expression was found to be increased in invasive and metastatic human breast cancer. AZDye555 fluorophore-labeled BLMP6 was developed as a reagent selectively binding to invasive and metastatic human breast cancer cells in tissue sections and homing to MDA-MB-231 metastases in mice. We show that radiolabeling BLMP6 with\n                  <jats:sup>68<\/jats:sup>\n                  Ga can be used for the detection of MDA-MB-231 metastases. We designed a peptide-drug conjugate consisting of monomethyl auristatin E (MMAE) and BLMP6 that preferentially kills aggressive cancer cells. Cytotoxicity of MMAE-BLMP6 against MDA-MB-231 tumors was confirmed\n                  <jats:italic>in vivo<\/jats:italic>\n                  . In an immunocompetent mouse model of B16F10 experimental lung metastases, treatment with MMAE-BLMP6 suppressed metastasis growth and improved survival. There was also a trend for metastasis suppression and survival improvement in the MDA-MB-231 experimental metastasis model. Our results suggest that fibulin-4 and BLMP6 may be further developed for the detection and targeting of metastatic human cancers.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Statement of significance<\/jats:title>\n                  <jats:p>This study identifies fibulin-4 as a protein highly expressed in breast cancer metastasis. It evaluates the application of peptide conjugates targeting fibulin-4 in mouse models as non-invasive probes for metastasis detection and cytotoxic drug delivery.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.06.18.657655","type":"posted-content","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:30:10Z","timestamp":1750375810000},"source":"Crossref","is-referenced-by-count":0,"title":["Fibulin-4 is highly expressed in metastatic breast cancer and can serve as a target of peptide-based imaging probes and experimental therapeutics"],"prefix":"10.64898","author":[{"given":"Alexes C.","family":"Daquinag","sequence":"first","affiliation":[{"name":"Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solmaz","family":"AghaAmiri","sequence":"additional","affiliation":[{"name":"Center for Translational Cancer Research, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Farmer","sequence":"additional","affiliation":[{"name":"Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"},{"name":"Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"},{"name":"Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhen C.","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Center for Translational Cancer Research, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Servando Hernandez","family":"Vargas","sequence":"additional","affiliation":[{"name":"Center for Translational Cancer Research, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin K.","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Texas Therapeutics Institute, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"An","sequence":"additional","affiliation":[{"name":"Texas Therapeutics Institute, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"},{"name":"Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Azhdarinia","sequence":"additional","affiliation":[{"name":"Center for Translational Cancer Research, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"},{"name":"Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail G.","family":"Kolonin","sequence":"additional","affiliation":[{"name":"Center for Metabolic and Degenerative Diseases, Institute of Molecular Medicine, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"},{"name":"Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and UTHealth, Houston, Texas 77030"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041204172964000_2025.06.18.657655v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01195-4"},{"key":"2026041204172964000_2025.06.18.657655v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00181-0"},{"key":"2026041204172964000_2025.06.18.657655v1.3","doi-asserted-by":"publisher","DOI":"10.46439\/signaling.1.020"},{"key":"2026041204172964000_2025.06.18.657655v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/nm1469"},{"key":"2026041204172964000_2025.06.18.657655v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3180"},{"key":"2026041204172964000_2025.06.18.657655v1.6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1015"},{"key":"2026041204172964000_2025.06.18.657655v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29344"},{"key":"2026041204172964000_2025.06.18.657655v1.8","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0582"},{"key":"2026041204172964000_2025.06.18.657655v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-024-07487-W"},{"key":"2026041204172964000_2025.06.18.657655v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAC394"},{"key":"2026041204172964000_2025.06.18.657655v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.169"},{"key":"2026041204172964000_2025.06.18.657655v1.12","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2012-5198"},{"key":"2026041204172964000_2025.06.18.657655v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114377"},{"key":"2026041204172964000_2025.06.18.657655v1.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901048116"},{"key":"2026041204172964000_2025.06.18.657655v1.15","doi-asserted-by":"crossref","unstructured":"Su CT , Urban Z . LTBP4 in Health and Disease. Genes (Basel) 2021;12","DOI":"10.1038\/s41419-021-04214-5"},{"key":"2026041204172964000_2025.06.18.657655v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/nm1048"},{"key":"2026041204172964000_2025.06.18.657655v1.17","first-page":"1","volume":"6","year":"2017","journal-title":"Non-glycanated Decorin is a Drug Target on Human Adipose Stromal Cells Molecular Therapy - Oncolytics"},{"key":"2026041204172964000_2025.06.18.657655v1.18","doi-asserted-by":"crossref","unstructured":"Hernandez Vargas S , Lin C , Voss J , Ghosh SC , Halperin DM , AghaAmiri S , et al. Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumors. J Biomed Opt 2020;25","DOI":"10.1117\/1.JBO.25.12.126002"},{"key":"2026041204172964000_2025.06.18.657655v1.19","unstructured":"Vargas SH , Lin C , AghaAmiri S , Voss J , Ikoma N , Tran Cao HS , et al. A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery. Proc SPIE Int Soc Opt Eng 2020;11222"},{"key":"2026041204172964000_2025.06.18.657655v1.20","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.7b00125"},{"key":"2026041204172964000_2025.06.18.657655v1.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.187971"},{"key":"2026041204172964000_2025.06.18.657655v1.22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3312"},{"key":"2026041204172964000_2025.06.18.657655v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23793-7"},{"key":"2026041204172964000_2025.06.18.657655v1.24","doi-asserted-by":"publisher","DOI":"10.1177\/1536012118801223"},{"key":"2026041204172964000_2025.06.18.657655v1.25","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0114"},{"key":"2026041204172964000_2025.06.18.657655v1.26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-0022"},{"key":"2026041204172964000_2025.06.18.657655v1.27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.3c00147"},{"key":"2026041204172964000_2025.06.18.657655v1.28","doi-asserted-by":"publisher","DOI":"10.1021\/jm800495u"},{"key":"2026041204172964000_2025.06.18.657655v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3472"},{"key":"2026041204172964000_2025.06.18.657655v1.30","first-page":"34","article-title":"Targeted Pro-apoptotic Peptides Depleting Adipose Stromal Cells Inhibit Tumor Growth","volume":"1","year":"2016","journal-title":"Mol Ther"},{"key":"2026041204172964000_2025.06.18.657655v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.148"},{"key":"2026041204172964000_2025.06.18.657655v1.32","doi-asserted-by":"crossref","unstructured":"Cho H , Shim MK , Moon Y , Song S , Kim J , Choi J , et al. Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy. Pharmaceutics 2022;14","DOI":"10.3390\/pharmaceutics14102131"},{"key":"2026041204172964000_2025.06.18.657655v1.33","doi-asserted-by":"crossref","unstructured":"Noda K , Kitagawa K , Miki T , Horiguchi M , Akama TO , Taniguchi T , et al. A matricellular protein fibulin-4 is essential for the activation of lysyl oxidase. Sci Adv 2020;6","DOI":"10.1126\/sciadv.abc1404"},{"key":"2026041204172964000_2025.06.18.657655v1.34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402767R"},{"key":"2026041204172964000_2025.06.18.657655v1.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.439158"},{"key":"2026041204172964000_2025.06.18.657655v1.36","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1100-9"},{"key":"2026041204172964000_2025.06.18.657655v1.37","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.3921"},{"key":"2026041204172964000_2025.06.18.657655v1.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4752-8"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.06.18.657655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T11:17:40Z","timestamp":1775992660000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.06.18.657655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1101\/2025.06.18.657655","relation":{},"subject":[],"published":{"date-parts":[[2025,6,19]]},"subtype":"preprint"}}